HomeCompareTVBCY vs JNJ

TVBCY vs JNJ: Dividend Comparison 2026

TVBCY yields 322.58% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TVBCY wins by $116.6K in total portfolio value
10 years
TVBCY
TVBCY
● Live price
322.58%
Share price
$0.62
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$146.9K
Annual income
$234.83
Full TVBCY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — TVBCY vs JNJ

📍 TVBCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTVBCYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TVBCY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TVBCY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TVBCY
Annual income on $10K today (after 15% tax)
$27,419.35/yr
After 10yr DRIP, annual income (after tax)
$199.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,786.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TVBCY + JNJ for your $10,000?

TVBCY: 50%JNJ: 50%
100% JNJ50/50100% TVBCY
Portfolio after 10yr
$88.6K
Annual income
$2,462.11/yr
Blended yield
2.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TVBCY
No analyst data
Altman Z
2.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TVBCY buys
0
JNJ buys
0
No recent congressional trades found for TVBCY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTVBCYJNJ
Forward yield322.58%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$146.9K$30.3K
Annual income after 10y$234.83$4,689.40
Total dividends collected$78.6K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TVBCY vs JNJ ($10,000, DRIP)

YearTVBCY PortfolioTVBCY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$26,829$16,129.03$10,592$272.30+$16.2KTVBCY
2$48,928$20,220.86$11,289$357.73+$37.6KTVBCY
3$69,585$17,232.07$12,123$472.89+$57.5KTVBCY
4$85,908$11,452.03$13,141$629.86+$72.8KTVBCY
5$98,528$6,606.73$14,408$846.81+$84.1KTVBCY
6$108,966$3,540.79$16,021$1,151.60+$92.9KTVBCY
7$118,423$1,829.85$18,122$1,588.22+$100.3KTVBCY
8$127,642$929.29$20,930$2,228.20+$106.7KTVBCY
9$137,045$468.05$24,792$3,191.91+$112.3KTVBCY
10$146,873$234.83$30,274$4,689.40+$116.6KTVBCY

TVBCY vs JNJ: Complete Analysis 2026

TVBCYStock

Television Broadcasts Limited, together with its subsidiaries, engages in terrestrial television broadcasting, program production, and other television-related activities. It operates through Hong Kong TV Broadcasting, Over-The-Top (OTT) Streaming, e-Commerce Business, Mainland China Operations, and International Operations segments. The Hong Kong TV Broadcasting segment is involved in the broadcasting of television programs and commercials on terrestrial TV platforms; production of programs; operation of online social media platform; and music entertainment, and event and digital marketing activities. The OTT Streaming segment provides OTT services; and operates website portals. The e-Commerce Business segment operates e-Commerce platforms under the names Ztore, Neigbuy, and Big Big Shop. The Mainland China Operations segment co-produces dramas; and distributes television programs and channels to telecast, video, and media operators in Mainland China. The International Operations segment offers pay television and OTT services to subscribers; and distributes television programs and channels to telecast, video, and media operators in Malaysia, Singapore and internationally. The company also offers agency services on design, production, and exhibition of advertisements, as well as film rights and management services; provides consultancy, management, and agency services to artistes; and produces, publishes, and licenses musical works and sells sound recordings, as well as offers corporate finance services. In addition, it produces motion pictures for theatrical release and distribution; and provides satellite and subscription television programs, and program licensing and dealership services. Further, the company engages in provision of programs and marketing materials; property investment and other activities; and online sale of groceries. The company was founded in 1967 and is based in Kowloon, Hong Kong.

Full TVBCY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TVBCY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TVBCY vs SCHDTVBCY vs JEPITVBCY vs OTVBCY vs KOTVBCY vs MAINTVBCY vs ABBVTVBCY vs MRKTVBCY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.